Globa Terra Acquisition Corp

The mechanical division of units shifts liquidity and risk allocation ahead of a de-SPAC transaction, allowing investors to price equity, leveraged derivatives, and deferred share rights independently. According to the July 24, 2025 press release, CEO Agustin Tristan Aldave and the company state that their acquisition strategy will focus exclusively on agribusiness and water sectors, targeting food-tech, ag-tech, bio-tech, controlled environment agriculture, open field crops, water utility, water treatment, pipelines, desalination, and other water solutions. The filing identifies D. Bolar Capital LLC as the sole book-running manager for the underwritten offering and confirms the SEC declared the registration statement effective on July 7, 2025. Although this 8-K contains no update on redemption deadlines, trust account reconciliations, extension mechanisms, or target selection progress, the unit split establishes the trading architecture that will dictate how sponsors, institutional allocators, and retail participants navigate pre-combination volatility and determine when warrant dilution or share conversion thresholds become actionable.

This filing formally locks the post-offering trust balance and statutory acquisition timeline, defining the exact redemption window and extension mechanics for public shareholders. The documented transfer of founder shares to advisors and executives, alongside a monthly $15,000 administrative services agreement and separate consulting arrangements with Meteora Capital, LLC and Meridien Peak, clarifies the sponsor’s ongoing compensation structure and pre-combination burn rate. With $1,004,288 in operating cash, $677,779 in working capital, deferred expenses of $150,000, and an unencumbered $450,000 lender facility, management states it holds sufficient capital to cover due diligence, travel, and structuring costs until the earlier of a business combination or one year from the audit report date. The notes confirm zero operating revenues to date and a strategic mandate confined to evaluating high-potential targets based in North America. Standard public warrant economics are codified at a $11.50 exercise price with a $18.00 redemption trigger, establishing baseline dilution parameters without amendment.

This is a new SPAC entering the market. Investors should note the trust value is exactly $10.00 per share at IPO, the deadline for a business combination is 15 months from July 10, 2025 (i.e., October 10, 2026, if extended to 21 months), and the sponsor has meaningful skin in the game with founder shares subject to forfeiture and lock-ups. The company's stated focus on agribusiness (food-tech, ag-tech, bio-tech, controlled environment agriculture, open field crops) and water (water utility, treatment, pipelines, desalination) may attract investors interested in those sectors. The filing includes all standard SPAC agreements with no unusual or adverse terms.

This filing sets all redemption mechanics, trust value, extension terms, dilution structure and sponsor economics for GTER. Investors now have a complete baseline to evaluate redemption risk, sponsor incentives, and deal timeline. Key metrics: Net tangible book value at no redemptions is $7.40-$7.42 per share (substantial dilution from $10.00). At maximum redemptions NTBV drops to $0.17-$0.18. The sponsor's founder shares cost $0.0043 each. The filing also discloses a material conflict of interest with Agrinam Acquisition Corp, another blank check company managed by the same team, which has priority over GTER for deals.

The acceleration schedule creates a definitive endpoint for capital raising, which dictates when IPO proceeds could enter the trust account and thereby sets the baseline funding level for any future business combination vote where shareholders exercise redemption rights. By tethering all distribution materials to the June 17, 2025 preliminary prospectus, D. Boral Capital LLC signals that sponsor claims regarding customers, revenue trajectories, target markets, technology roadmaps, or partnership pipelines have not been updated since that date. The letter also functions as a compliance ledger for banker conduct, documenting that distribution controls and compensation arrangements satisfy 1934 Exchange Act standards. Investors tracking extension deadlines or redemption thresholds should treat this filing as a procedural milestone that freezes the disclosure baseline and locks in the timing window for trust accumulation.

This filing contains the definitive terms for a new SPAC IPO. It establishes the trust value per share ($10.37 from a per-unit $10.00 trust deposit plus interest) and start of the 15-month redemption clock upon closing. It provides comprehensive sponsor compensation and dilution details (sponsor pays nominal $0.0043 per founder share). It discloses the material conflict of interest with affiliate Agrinam and the general priority it holds over acquisition opportunities. It details the unique structure of sponsor non-managing members who can buy units and vote but are not bound by lock-ups. It also discloses that the Sponsor transferred 87,500 founder shares to Meridien Peak as compensation.

It locks in pre-effectiveness disclosures on sponsor retained equity, private placement investor allocations, and class-specific forfeiture mechanics that directly shape post-listing capital structure and dilution exposure. For investors monitoring redemption windows and extension triggers, it confirms the SPAC remains in the SEC review and prospectus finalization phase rather than executing a de-SPAC transaction or convening a shareholder vote, meaning the trust corpus, distribution formula, and deadline calendar remain governed by prior filings. The precise mapping of unit classes ensures investors can accurately model control rights and economic participation once the registration statement becomes effective.

For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: This comment letter indicates active SEC staff scrutiny of the sponsor’s equity stack and private placement structuring. Until Amendment No. 1 is fully addressed and the registration becomes effective, the SPAC cannot file a target announcement, definitive proxy, or formal extension solicitation that relies on an effective prospectus, thereby mechanically delaying the timeline for shareholder redemption windows or extension votes. The mandate to verify the Private Placement Investor’s affiliation highlights SEC attention to potential related-party compensation structures, a critical governance variable when assessing whether management may incentivize trust preservation via extensions over accelerated combinations. Regarding other substance: Beyond the SEC’s stated requirements, the referenced page locations (page 30, page 33), the contact directory for Jeffrey Lewis, Shannon Menjivar, Stacie Gorman, and Pamela Long, and the mailing address at Homero 109, Despacho 1602, Polanco, Ciudad de Mexico, the document contains no information on customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. All claims regarding unit classifications, forfeiture triggers, and holding allocations are sourced exclusively from the SEC Division of Corporation Finance’s May 29, 2025 letter.

This advances Globa Terra's IPO process as a searching SPAC. The prospectus says the offering is 15,217,000 units at $10.00 per unit, with trust proceeds of $152,930,850 (or $175,870,478 if the over-allotment option is exercised in full), initially anticipated at $10.05 per public share. The company has 15 months after closing to complete a business combination, extendable by up to two three-month periods if the sponsor deposits $1,521,700 (or up to $1,749,955 with full over-allotment) per extension, and shareholders may vote on additional extensions. It also details sponsor compensation of $15,000 per month, founder share and private placement economics, and redemption mechanics. No target or deal calendar is involved yet because this is still a pre-IPO registration.

For investors tracking redemption mechanics, removing the $5,000,001 net tangible asset floor eliminates a previous structural ceiling that constrained maximum public share redemptions, altering how high redemption scenarios are modeled at the time of the special meeting. The confirmed $10.05 per share baseline directly sets the expected trust account distribution at business combination. On dilution and sponsor alignment, the disclosed insider ratio (one and one-fourth units and two and one-half restricted shares per $10 invested) paired with the 1,012,500 restricted Class A shares quantifies the baseline post-offering ownership erosion public shareholders face before any target acquisition. The reallocation of advisory costs—cutting Meteora’s closing payout to $150,000 while granting Meridien immediate vesting of 87,500 founder shares plus cash fees—preserves more IPO proceeds for the transaction pool, changes the cash-burn profile during the search period, and shifts third-party consultant incentives away from warrant-heavy models toward equity-plus-cash compensation. All claims are sourced exclusively to the Company’s filings and the statements relayed by counsel Gil Savir of Paul Hastings LLP.

Per SEC staff guidance, the registration statement remains non-effective until amendments addressing these fourteen points accelerate its review, directly delaying the capital raise needed for trust funding, operational runway, and subsequent merger deadlines or extension votes. The structural divergence between private placement economics and public terms, alongside unquantified dilution from private warrants and multi-tier founder share forfeiture, introduces sponsor-public interest misalignment that could compress viable redemption windows or alter merger consideration math. The explicit tension between the company's $5,000,001 net tangible asset floor and current dilution/redemption modeling challenges default liquidation assumptions, while the $500,000 undocumented advisory fee and dual-consultant oversight framework add hidden cost layers and governance risk preceding any business combination announcement. Required segment reporting corrections under ASC 280-10-50-20 further rectify financial statement gaps that currently obscure operational transparency before the next shareholder action period.

These regulated updates materially reframe the disclosed mechanics governing shareholder redemption calculations and sponsor accountability. As stated by the company, issuing the 325,000 director and management shares directly instead of indirectly removes ambiguity around board alignment and reduces reliance on sponsor intermediation during proxy solicitations or extension votes. Disclosures on recapitalization levers to defend the 20% stake supply concrete parameters for investors modeling dilution triggers that could suppress net trust recoveries upon redemption. The staff-composed warning regarding sponsor exit risk formally catalogs execution uncertainty for parties monitoring deadline proximity. Separately, the company’s confirmation that Meteora and Meridien function as independent advisors—potentially billing the SPAC and sponsor respectively—surfaces contractual conflict pathways and resolution protocols detailed in the amended prospectus, while reaffirming the issuer’s structure as a Cayman Islands exempted company governed by Regulation S-K Items 1602 and 1603 compliance standards as audited by SEC staff across the referenced registration statement pages.

Establishes the complete structural framework for the SPAC IPO, including trust value per share ($10.05), redemption mechanics, extension provisions, sponsor economics, and lock-up terms. This is the foundational document for all future redemption deadline tracking, trust account monitoring, and assessment of sponsor conduct and deal progress. The filing also reveals potential conflicts: management's involvement with other SPACs (particularly Agrinam, which has priority for opportunities) and the near-term liquidity risk before IPO proceeds are received.

These mandated disclosures determine whether shareholders possess the precise governance, alignment, and dilution parameters necessary to calibrate redemption strategies, weigh extension proposals, and assess merger viability. Direct clarity on sponsor exit risk, voting incentives, and independent director equity exposure shifts the baseline assessment of sponsor commitment, which historically drives retail redemption cascades and dictates institutional negotiation posture. Until the amended registration statement satisfies these SEC requirements, market participants cannot reliably price the trust account against anticipated capital calls or model post-combination ownership stakes, rendering this comment letter the decisive weekly indicator of deal pacing, sponsor conduct, and shareholder decision-making prerequisites.

The Company’s amended disclosures materially recalibrate investor expectations around redemption timing, sponsor alignment, and target selection. The illustrative disclosure prepared by the Company ties CFIUS scrutiny and foreign beneficial ownership directly to a compressed timeline; because the Company identifies CEO Agustin Tristan Aldave as a Mexico resident and independent director Jesus Treme as a Mexico resident, with majority non-U.S. citizenship among management and the board, an initial business combination with a U.S. target could trigger mandatory or voluntary CFIUS filings. If regulatory review drags past 18 months (or 24 months fully extended), the Company outlines a liquidation scenario capping returns at $10.00 per share while eliminating warrant value. Expanded conflict warnings and explicit sponsor forfeiture/transfer rights suggest founder-share voting behavior may diverge from public shareholder preferences, particularly if non-managing members purchase substantial units and acquire differing economic interests. The 20% maintenance mechanism and updated dilution modeling demonstrate how IPO resizing and advisory fee structures will mechanically compress public float economics. Beyond mechanics, the Company provides substantive context on its strategic posture: it positions Meteora and Meridien Peak as non-promoter strategic advisors engaged solely for post-founding guidance, with Meridien Peak’s compensation tied to a formula receiving '30% of the difference' between total founder shares and those allocated to bona fide cash investors. The filing also notes significant competition from numerous other entities seeking targets, which the Company acknowledges may reduce the attractiveness of negotiated acquisition terms. These parameters define the risk-return profile, governance oversight, and realistic deal universe available to GTER public shareholders ahead of pricing.

This filing establishes the core SPAC mechanics – redemption rights, extension terms, trust size, sponsor economics, and conflict risks – that investors must evaluate before deciding to participate in the IPO or trade post-offering. The disclosed dilution from founder shares (nominal cost of $0.0035 vs. $10.00 IPO price), the ability to extend without shareholder vote for up to two three-month periods, and the priority given to Agrinam are critical to understanding downside risk and sponsor incentives.

Division of Corporation Finance comments act as a mandatory clearinghouse step before an S-1 can be declared effective, meaning GTER cannot trade publicly, deposit trust proceeds, or formally launch its business combination search until these disclosures are filed. The SEC’s stipulations on extension caps, redemption/dilution mechanics, sponsor alignment through private placement warrants and founder shares, and the impact of foreign sponsorship will directly shape shareholder redemption calculus, governance oversight, and timeline exposure. Explicit tracking of past SPAC performance, advisor distinctness, lock-up parameters, and tax/cost structures removes ambiguity around capital deployment and aligns the filing with securities reporting standards, determining the structural safeguards that will protect public holders during future combination votes or liquidation events.

This filing is the foundational disclosure for the SPAC, providing investors with all material terms of the offering, including the $10.00 per-unit trust, 18-month (extendable to 24-month) deadline, redemption rights, sponsor economics, conflicts of interest with Agrinam, and the business strategy. It is critical for evaluating the investment opportunity and redemption timing.

What changed: Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed by Globa Terra Acquisition Corp (GTER). Trust account value increased to $178.4 million ($10.19 per public share) due to $3.4 million interest income; no business combination has been announced; the deadline to complete a deal is 15 months from the July 2025 IPO (by October 9, 2026), with potential sponsor-funded extensions up to 21 months; the auditor issued a going-concern qualification; no extensions have been taken yet; the company remains in the searching phase with no definitive agreement. Why it matters: Investors tracking redemption mechanics now have an updated trust value above the $10.00 IPO price; the clock is ticking toward the October 2026 deadline, and the lack of a deal increases the risk of liquidation; the going-concern paragraph underscores the urgency; the increased trust value improves the per-share redemption amount if a deal is not completed.

What changed: A Joint Filing Agreement (Exhibit 99.1) accompanying a Schedule 13G, dated February 17, 2026. Per the signatories, Shane Cullinane (Chief Operating Officer) and Allyson Hanlon (Deputy General Counsel) executed the agreement on behalf of seven LMR Partners entities, with Ben Levine and Stefan Renold signing individually. The exhibit records an administrative linkage of these holders into a single reporting vehicle. It contains zero references to GTER’s redemption deadline, trust value per share, extension mechanics, target deal progress, or sponsor conduct. No share quantities, percentages, prices, or transaction dates are disclosed. Why it matters: As filed by the undersigned, this document confirms the procedural binding of LMR Partners’ international affiliates and principals to joint 13G amendments going forward. Because the exhibit supplies no beneficial ownership percentage, acquisition date, or statement of purpose, it does not clarify current positioning relative to regulatory thresholds. For investors tracking capital allocation ahead of a business combination vote, the absence of quantitative disclosure leaves redemption floor assumptions, trust retention calculations, and sponsor alignment signals unverified until the main Schedule 13G body is released. The filing remains purely administrative.

What changed: A routine compliance exhibit consisting of two limited powers of attorney (Exhibit A and Exhibit B) attached to a Schedule 13G/A filing, executed pursuant to the Securities Exchange Act of 1934 to authorize Takahiro Katsura to sign and file Form 13G amendments on behalf of Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC. Filed on 2-12-2026 and signed by Hidekatsu Take (Deputy President & Corporate Executive for Mizuho Financial Group; Managing Executive Officer, Head of Global Corporate & Investment Banking Division, Head of Global Transaction Banking Unit for Mizuho Bank) and Adam Hopkins (Chief Legal Officer and Managing Director, General Counsel for Mizuho Americas LLC and Mizuho Securities USA LLC), the filing updates Mizuho entities' internal delegation for executing Section 13(d) and Section 13(g) disclosures. Bearing on SPAC mechanics, the document confirms no adjustments to GTER’s redemption deadlines, trust value ($10.37 per share), extension voting windows, target acquisition progress, or sponsor conduct. It contains no proposals for trust account reallocations, redemption price modifications, or deadline suspensions. Why it matters: This administrative instrument solely governs SEC filing execution authority for beneficial ownership reporting. It introduces no claims regarding GTER’s customers, revenue, market size, strategy, technology, partnerships, litigation, or target-search personnel. The referenced entity headquarters (1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan; 1271 Avenue of the Americas, NY, NY 10020, USA) and dated signatures function as corporate records only. Investors tracking redemption triggers, trust preservation, extension resolutions, deal timelines, or sponsor governance should note that this exhibit maintains compliance infrastructure without altering shareholder economics or contractually binding SPAC milestones.

What changed: Quarterly report on Form 10-Q (unaudited condensed financial statements). This is Globa Terra's first 10-Q since its July 10, 2025 IPO, covering the stub period from IPO through September 30, 2025. The filing establishes baseline trust value ($176,663,659, or $10.10 per public share after interest) and confirms no business combination agreement is in place. The company had $691,042 of cash outside the trust, net income of $1,312,252 for the period (entirely from trust interest). The deadline to complete a deal is 15 months from IPO (October 9, 2026), with up to two 3-month extensions available. Management disclosed substantial doubt about going concern if no deal is done by that date. Sponsor conduct: on March 25, 2025, the Sponsor voluntarily surrendered 1,354,317 founder shares for no consideration. Why it matters: This filing establishes the baseline redemption value ($10.10 per share as of September 30, 2025). The trust value is $176.66M, consisting of the $174.995M IPO deposit plus $1.67M of earned interest. Shareholders considering redemption should note: the company is early in its search period, no target has been announced, and it has ample time (until October 2026) to find a deal. The Sponsor's voluntary surrender of founder shares and transfer of shares to independent directors/management are positive governance signals.

What changed: SEC Form 12b-25 Notification of Late Filing regarding Globa Terra Acquisition Corporation’s delayed Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Chief Financial Officer Katherine Chiles notified the SEC that the Form 10-Q missed its regulatory deadline because the Company and its auditor require additional time to complete the final review of the financial statements and disclosures. The filing commits to submitting the report on or before the fifth calendar day following the prescribed due date. All other periodic reports under Section 13 or 15(d) during the preceding twelve months have been filed on time. No changes to the SPAC’s redemption calendar, trust distribution framework, or extension voting procedures are disclosed in this submission. Why it matters: Administrative delays do not alter existing trust structures or trigger automatic redemption rights, but they extend the period during which shareholders lack updated quarterly financials to evaluate sponsor execution and target pipeline viability. The CFO attributes the lag exclusively to standard audit finalization steps and cites a clean compliance history over the preceding twelve months, which suggests the postponement is procedural rather than indicative of sponsorship misconduct or operational distress. However, extended preparation cycles can compress deal negotiation windows, potentially pressuring sponsors to finalize merger targets faster, request extension votes later, or face heightened scrutiny during future redemption periods. The filing also establishes Chief Financial Officer Katherine Chiles as the designated contact ((404) 547-0225) for inquiries, confirming continued executive oversight despite the reporting pause. No claims regarding customers, revenue, market size, technology, partnerships, litigation, or personnel changes appear in the text.

What changed: An Exhibit A joint filing agreement attached to an amended Schedule 13G beneficial ownership report for securities of Globa Terra Acquisition Corp. The provided excerpt contains only the signature and consent language permitting joint filing under Rule 13d-1(k). It identifies Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr. as co-filers. No beneficial ownership percentages, amendment effective dates, acquisition costs, statements of purpose, or SPAC structural mechanics are disclosed in this text. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, or sponsor conduct, this exhibit provides no new operational data. It confirms routine administrative consolidation, allowing affiliated Harraden Circle vehicles to submit a single amended 13G through a common Managing Member. Without the accompanying Schedule 13G/A pages, no shifts in control, economic interest, redemption exposure, or acquisition-stage disclosures can be verified from this excerpt alone.

What changed: A Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13G beneficial ownership report. The filing establishes that Globa Terra Sponsor LLC, Globa Terra Management LLC, and Agustin Tristan Aldave will report their combined beneficial ownership of Class A ordinary shares jointly under SEC Rule 13d-1(k). The document records no acquisitions, dispositions, pledges, or changes in voting or investment power. Redemption windows, trust account mechanics, extension vote triggers, business combination negotiations, and sponsor conduct outside of this reporting aggregation remain untouched. Why it matters: This is a standard compliance exhibit designed to consolidate SEC reporting for affiliated insiders. The filing contains no substantive commercial or operational disclosures: there are no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because it conveys zero transactional data, financial metrics, or forward-looking statements, it does not shift the redemption calendar, alter trust distribution sequencing, or signal progress toward a merger. Investors should treat it as routine regulatory housekeeping with no direct bearing on capital allocation or liquidity timing.

What changed: A Schedule 13G joint filing agreement and attached Exhibit A submitted to report beneficial ownership of Ordinary Shares of Globa Terra Acquisition Corporation under Rule 13d-1(k) of the Securities Exchange Act of 1934. Nothing changed regarding redemption deadlines, trust value, extension provisions, business combination progress, or sponsor conduct. The filing does not modify the SPAC’s SEARCHING status or any shareholder voting/redemption mechanics. It simply records that Westchester Capital Management, LLC; Westchester Capital Partners, LLC; Virtus Investment Advisers, LLC; and The Merger Fund are jointly fulfilling a regulatory ownership disclosure obligation. Why it matters: This administrative submission confirms institutional position-holding, verified by signature blocks executed on November 14, 2025 by CaSaundra Wu (Chief Compliance Officer), Chetram Persaud (Chief Compliance Officer), and Daphne Chisolm (Vice President, Counsel and Assistant Secretary). For investors tracking SPAC mechanics, the document contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or corporate personnel beyond the named signatories. It provides no updates to redemption calendars, alters no trust valuations, indicates no merger timeline shifts, and reveals no sponsor conduct developments. Its sole relevance lies in identifying four specific fund vehicles currently holding or having recently crossed the 5% beneficial ownership threshold, requiring no mechanical adjustment to existing shareholder expectations.

What changed: In its own terms, this document is an Exhibit A and Exhibit B containing Limited Powers of Attorney executed pursuant to Section 13(d) and 13(g) of the Securities Exchange Act of 1934, submitted as part of a Schedule 13G filing for Globa Terra Acquisition Corp. Per the provided text, the document reports nothing concerning redemption deadlines, trust account mechanics, extension voting, business combination deal progress, or sponsor conduct. It functions exclusively as a procedural authorization instrument for SEC filing compliance. Why it matters: While operationally inert regarding SPAC redemption or merger timelines, the filing substantively catalogs corporate governance authorizations made by Mizuho-affiliated entities. Hidekatsu Take (Deputy President & Corporate Executive of Mizuho Financial Group, Inc.) and Hidekatsu Take (Managing Executive Officer, Head of Global Corporate & Investment Banking Division of Mizuho Bank, Ltd.) execute the instruments. Adam Hopkins (Chief Legal Officer and Managing Director, General Counsel of Mizuho Americas LLC and Mizuho Securities USA LLC) also signs on behalf of his affiliated entities. These parties grant Takahiro Katsura (Managing Director, Head of Global Branches & Subsidiaries Coordination Office, Global Corporate Function Coordination Department) power of attorney to execute, amend, supplement, and timely file Form 13G with the U.S. Securities and Exchange Commission regarding the filers’ holdings and transactions. Filers classify Mizuho Bank, Ltd. as 'A non-U.S. institution equivalent to Bank', Mizuho Americas LLC as 'A parent holding company', and Mizuho Securities USA LLC as 'A registered Broker-Dealer'. Principal office locations are stated as 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan and 1271 Avenue of the Americas, NY, NY 10020, USA. All executions are dated 11-13-2025. The text contains no claims regarding customer relationships, revenue streams, market size, strategic initiatives, technology capabilities, partnership structures, pending litigation, or operational personnel beyond these governance appointments. No numerical computations are performed, no rounding occurs, and no standard trust share conventions are applied or referenced.